Clinical Trial Results Prove Positive For Samumed
Monday, July 31, 2017
Samumed, the San Diego biotech with a $12 billion valuation, has wrapped up a mid-stage clinical trial that has the company optimistic about its future...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in

- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know